Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery - Yahoo Finance
markets.businessinsider.comSubmitted by businessinsider9738 in business
Recursion has a library of 3 trillion searchable genes that will serve as the foundation for the company's AI-powered drug discovery program.